phenol and Neoplasms
phenol has been researched along with Neoplasms in 67 studies
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the efficacy of percutaneous cervical cordotomy (PCC) and subarachnoid phenol block using fluoroscopy (SAPB-F) for control of chest and/or back pain from costopleural syndrome." | 9.07 | Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome. ( Amakawa, K; Arai, T; Kimura, S; Nagaro, T; Tabo, E; Yamauchi, Y, 1994) |
| "We examined the efficacy of percutaneous cervical cordotomy (PCC) and subarachnoid phenol block using fluoroscopy (SAPB-F) for control of chest and/or back pain from costopleural syndrome." | 5.07 | Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome. ( Amakawa, K; Arai, T; Kimura, S; Nagaro, T; Tabo, E; Yamauchi, Y, 1994) |
| " In addition, characterization of the UGT1A locus and genetic studies directed at understanding the role of bilirubin glucuronidation and the biochemical basis of the clinical symptoms found in unconjugated hyperbilirubinemia have uncovered the structural gene polymorphisms associated with Crigler-Najjar's and Gilbert's syndrome." | 4.80 | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. ( Strassburg, CP; Tukey, RH, 2000) |
| " In this review, we analyze selective (poly)phenol mechanisms in senescent and cancer cells to discriminate between in vitro and in vivo evidence and human applications considering (poly)phenol bioavailability, the influence of the gut microbiota, and their dose-response effects." | 3.01 | Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols. ( Buriani, A; Cassidy, A; Davinelli, S; De Vivo, I; Fortinguerra, S; Scapagnini, G; Sorrenti, V, 2023) |
| " Nanodelivery emerges as a promising way to improve the oral bioavailability and anticancer activity of catechins." | 2.72 | Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity. ( Huang, Q; Jiang, Y; Jiang, Z; Ma, L, 2021) |
| "Cancer metastasis is the major cause of cancer-related death, and chemoprevention is defined as the use of natural or synthetic substances to prevent cancer formation or cancer progress." | 2.48 | Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. ( Weng, CJ; Yen, GC, 2012) |
| "The management of opioid resistant cancer pain is a significant issue for palliative medicine." | 2.44 | [Cancer pain treatment with nerve blocks and neuroablative procedures]. ( Nagaro, T; Tsubota, S, 2007) |
| "This article summarizes the possible cancer-preventive and -enhancing mechanisms of dietary antioxidants, with an emphasis on epigenetic mechanisms." | 2.43 | Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis. ( Lee, HJ; Lee, KW, 2006) |
| "Patients with advanced cancer may present complex sets of symptoms, of which pain is the most prevalent." | 2.42 | [Neurolytic blocks for cancer pain--still a useful therapeutic strategy]. ( Bjørgo, S; Hauser, M; Kongsgaard, UE, 2004) |
| "Pre-treatment with gallic acid significantly rendered K562 cells more susceptible to NK cell-mediated necrosis, while pre-treatment with rutin significantly rendered K562 cells more susceptible to apoptosis." | 1.33 | Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line. ( Andrikopoulos, NK; Dedoussis, GV; Kaliora, AC, 2005) |
| "Four cases of cancer patients whose intractable pain was treated by the authors using intrathecal neurolysis are presented." | 1.32 | Intrathecal neurolytic blocks for the relief of cancer pain. ( Candido, K; Stevens, RA, 2003) |
| "Effective control of cancer pain can now be achieved in a high proportion of patients with rigorously applied pharmacologic treatment, reducing the need for more demanding invasive procedures." | 1.29 | Spinal neurolysis for cancer pain: indications and recent results. ( Patt, RB; Reddy, S, 1994) |
| "Fifteen patients with cancer pain (average age of 61 years) were treated with serial epidural phenol in glycerin injections." | 1.28 | Mapping the spread of epidural phenol in cancer pain patients by radionuclide admixture and epidural scintigraphy. ( Finch, PM; Lovegrove, FT; Salmon, JB; Warwick, A, 1992) |
| " We observed excesses of cancer of the esophagus, cancer of the kidney, and Hodgkin's disease among workers exposed to phenol, but none of these excesses showed a dose-response relation with exposure to phenol." | 1.28 | Mortality among industrial workers exposed to phenol. ( Blair, A; Chandler, J; Dosemeci, M; Stewart, PA; Trush, MA, 1991) |
Research
Studies (67)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (28.36) | 18.7374 |
| 1990's | 6 (8.96) | 18.2507 |
| 2000's | 12 (17.91) | 29.6817 |
| 2010's | 16 (23.88) | 24.3611 |
| 2020's | 14 (20.90) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Tukey, RH | 1 |
| Strassburg, CP | 1 |
| Carradori, S | 1 |
| De Monte, C | 1 |
| D'Ascenzio, M | 1 |
| Secci, D | 1 |
| Celik, G | 1 |
| Ceruso, M | 1 |
| Vullo, D | 1 |
| Scozzafava, A | 1 |
| Supuran, CT | 1 |
| Liu, X | 2 |
| Zhao, K | 1 |
| Cao, J | 1 |
| Qi, X | 1 |
| Wu, L | 1 |
| Shen, S | 1 |
| Kar, B | 1 |
| Shanavas, S | 1 |
| Nagendra, AH | 1 |
| Das, U | 1 |
| Roy, N | 1 |
| Pete, S | 1 |
| Sharma S, A | 1 |
| De, S | 1 |
| Kumar S K, A | 1 |
| Vardhan, S | 1 |
| Sahoo, SK | 1 |
| Panda, D | 1 |
| Shenoy, S | 1 |
| Bose, B | 1 |
| Paira, P | 1 |
| Schwartz, ZT | 1 |
| Theisen, PD | 1 |
| Bjornstal, OT | 1 |
| Rodebaugh, M | 1 |
| Jemal, MA | 1 |
| Lee, D | 1 |
| Shelton, SD | 1 |
| Zhao, Z | 1 |
| Du, L | 1 |
| Kerwin, SM | 1 |
| Lanuza, F | 1 |
| Zamora-Ros, R | 1 |
| Rostgaard-Hansen, AL | 1 |
| Tjønneland, A | 1 |
| Landberg, R | 1 |
| Halkjær, J | 1 |
| Andres-Lacueva, C | 1 |
| Chandra Joshi, D | 1 |
| Ashokan, A | 1 |
| Jayakannan, M | 1 |
| Singh Tuli, H | 1 |
| Kumar, A | 1 |
| Ramniwas, S | 1 |
| Coudhary, R | 1 |
| Aggarwal, D | 1 |
| Kumar, M | 1 |
| Sharma, U | 1 |
| Chaturvedi Parashar, N | 1 |
| Haque, S | 1 |
| Sak, K | 1 |
| Abdelghaffar, NA | 1 |
| Farahat, TE | 1 |
| Ojeda, A | 1 |
| Vallverdu, J | 1 |
| Dürsteler, C | 1 |
| Ferreira-Dos-Santos, G | 1 |
| Sorrenti, V | 1 |
| Buriani, A | 1 |
| Fortinguerra, S | 1 |
| Davinelli, S | 1 |
| Scapagnini, G | 1 |
| Cassidy, A | 1 |
| De Vivo, I | 1 |
| Zhang, C | 2 |
| Wu, J | 2 |
| Liu, W | 1 |
| Zheng, X | 1 |
| Wang, P | 1 |
| Hernández-Porras, BC | 2 |
| Rocha, A | 1 |
| Juarez, AM | 1 |
| Rocha-Romero, A | 1 |
| Juárez-Lemus, ÁM | 1 |
| Elkoundi, A | 1 |
| Aguilar, LE | 1 |
| Chalony, C | 1 |
| Kumar, D | 1 |
| Park, CH | 1 |
| Kim, CS | 1 |
| Jiang, Y | 1 |
| Jiang, Z | 1 |
| Ma, L | 1 |
| Huang, Q | 1 |
| Zhang, D | 1 |
| Le, H | 1 |
| Cruz-Chuh, JD | 1 |
| Bobba, S | 1 |
| Guo, J | 1 |
| Staben, L | 1 |
| Ma, Y | 1 |
| Kozak, KR | 1 |
| Lewis Phillips, GD | 1 |
| Vollmar, BS | 1 |
| Sadowsky, JD | 1 |
| Vandlen, R | 1 |
| Wei, B | 1 |
| Su, D | 1 |
| Fan, P | 1 |
| Dragovich, PS | 1 |
| Khojasteh, SC | 1 |
| Hop, CECA | 1 |
| Pillow, TH | 1 |
| Graça, VC | 1 |
| Dias, MI | 1 |
| Barros, L | 1 |
| Calhelha, RC | 1 |
| Santos, PF | 1 |
| Ferreira, ICFR | 1 |
| Zhou, L | 5 |
| Ge, X | 3 |
| Liu, J | 1 |
| Zhou, J | 3 |
| Wei, S | 3 |
| Li, F | 1 |
| Shen, J | 3 |
| Jin, S | 1 |
| Gu, Z | 1 |
| Tian, G | 1 |
| Yan, L | 1 |
| Ren, W | 1 |
| Yin, W | 1 |
| Zhang, X | 2 |
| Hu, Z | 1 |
| Zhao, Y | 2 |
| Yang, C | 1 |
| Liu, Q | 1 |
| He, D | 1 |
| Na, N | 1 |
| Ouyang, J | 1 |
| Braakman, RB | 1 |
| Sieuwerts, AM | 1 |
| Umar, A | 1 |
| Hou, Z | 1 |
| Deng, K | 1 |
| Li, C | 1 |
| Deng, X | 1 |
| Lian, H | 1 |
| Cheng, Z | 1 |
| Jin, D | 1 |
| Lin, J | 1 |
| Shi, C | 1 |
| Xu, MJ | 1 |
| Bayer, M | 1 |
| Deng, ZW | 1 |
| Kubbutat, MH | 1 |
| Wätjen, W | 1 |
| Waejen, W | 1 |
| Proksch, P | 1 |
| Lin, WH | 1 |
| Koyyalagunta, D | 1 |
| Burton, AW | 1 |
| Messaoudi, S | 1 |
| Hamze, A | 1 |
| Provot, O | 1 |
| Tréguier, B | 1 |
| Rodrigo De Losada, J | 1 |
| Bignon, J | 1 |
| Liu, JM | 1 |
| Wdzieczak-Bakala, J | 1 |
| Thoret, S | 1 |
| Dubois, J | 1 |
| Brion, JD | 1 |
| Alami, M | 1 |
| Weng, CJ | 1 |
| Yen, GC | 1 |
| Yu, B | 1 |
| Fu, J | 1 |
| Gutiérrez, C | 1 |
| Bruera, E | 1 |
| Guo, Y | 1 |
| Palla, S | 1 |
| Ali, SM | 1 |
| Olivo, M | 2 |
| SAGI, E | 1 |
| PLESS, J | 1 |
| BOUTWELL, RK | 1 |
| BOSCH, DK | 1 |
| ITO, Y | 1 |
| MONTREUIL, J | 1 |
| SEGARD, E | 1 |
| YAMANA, K | 1 |
| de AZEVEDO, SB | 1 |
| GORDON, RA | 1 |
| GOEL, SB | 1 |
| SHEPHERD, GR | 1 |
| PETERSEN, DF | 1 |
| GENTIL, F | 1 |
| RUSSO, RP | 1 |
| MONTI, A | 1 |
| DE ALMEIDA, AP | 1 |
| FORTUNAA, DO | 1 |
| STOVNER, J | 1 |
| ENDRESEN, R | 1 |
| LOURIE, H | 1 |
| VANASUPA, P | 1 |
| SMITH, MC | 1 |
| WILKINSON, HA | 1 |
| MARK, VH | 1 |
| WHITE, JC | 2 |
| MAHER, RM | 1 |
| MARK, FH | 1 |
| ZERVAS, NT | 1 |
| ERVIN, FR | 1 |
| RICHARDSON, EP | 1 |
| Candido, K | 1 |
| Stevens, RA | 1 |
| Kongsgaard, UE | 1 |
| Bjørgo, S | 1 |
| Hauser, M | 1 |
| Turker, G | 1 |
| Basagan-Mogol, E | 1 |
| Gurbet, A | 1 |
| Ozturk, C | 1 |
| Uckunkaya, N | 1 |
| Sahin, S | 1 |
| Dedoussis, GV | 1 |
| Kaliora, AC | 1 |
| Andrikopoulos, NK | 1 |
| He, H | 1 |
| Zhou, Y | 1 |
| Liang, F | 1 |
| Li, D | 1 |
| Yang, L | 1 |
| Zhou, X | 1 |
| Cao, X | 1 |
| Lee, KW | 1 |
| Lee, HJ | 1 |
| Chin, W | 1 |
| Nagaro, T | 2 |
| Tsubota, S | 1 |
| Chio-Srichan, S | 1 |
| Réfrégiers, M | 1 |
| Jamme, F | 1 |
| Kascakova, S | 1 |
| Rouam, V | 1 |
| Dumas, P | 1 |
| Amakawa, K | 1 |
| Yamauchi, Y | 1 |
| Tabo, E | 1 |
| Kimura, S | 1 |
| Arai, T | 1 |
| Patt, RB | 1 |
| Reddy, S | 1 |
| Antila, H | 1 |
| Kirvelä, O | 1 |
| Salmon, JB | 1 |
| Finch, PM | 1 |
| Lovegrove, FT | 1 |
| Warwick, A | 1 |
| Dosemeci, M | 1 |
| Blair, A | 1 |
| Stewart, PA | 1 |
| Chandler, J | 1 |
| Trush, MA | 1 |
| Vanier, T | 1 |
| Kuś, M | 1 |
| Dobrogowski, J | 1 |
| Batra, UK | 1 |
| Sadana, JR | 1 |
| Gupta, RK | 1 |
| Beliaev, DG | 1 |
| Frid, IA | 1 |
| Genin, IB | 1 |
Clinical Trials (2)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management: A Randomized Controlled Trial of Efficacy and Safety[NCT05427058] | 36 participants (Anticipated) | Interventional | 2022-08-01 | Not yet recruiting | |||
| The Efficacy of Superior Hypogastric Blockade for Postoperative Pain[NCT03428152] | 78 participants (Actual) | Observational [Patient Registry] | 2018-02-09 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trial Outcomes
Duration of Operation
the time from the the first incision to the skin to skin closure. (NCT03428152)
Timeframe: from the induction of anesthesia and the end of the surgery
| Intervention | minutes (Mean) |
|---|---|
| Hypo | 115.83 |
| NoHypo | 114.16 |
Length of Hospital Stay
length of hospital stay time will be recorded (NCT03428152)
Timeframe: assessed up to 1 week
| Intervention | days (Mean) |
|---|---|
| Hypo | 2.66 |
| NoHypo | 2.96 |
Rescue Analgesic Time
Time to first analgesic demand at gynecology ward (after transfer from PACU to gynecology ward) (NCT03428152)
Timeframe: 48 hours (time to the first analgesic demand will be recorded)
| Intervention | minutes (Mean) |
|---|---|
| Hypo | 627 |
| NoHypo | 203.83 |
Number of Participants With Complications Due to SHP Block
intra/postoperative complications will be noted. (post-operative nausea and vomiting (PONV) or others: ie: intra-vascular local anesthetic injection, vascular puncture, hemodynamical changes after injection,.. ) (NCT03428152)
Timeframe: From the SHP block time (intraoperative) until discharge
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| PONV | others | |
| Hypo | 7 | 0 |
| NoHypo | 8 | 0 |
Postoperative Analgesic Consumption
"Total number of non-steroid anti-inflammatory drug (NSAID) and opioid vials that are applied to patients in post-anesthesia care unit (PACU) and at ward will be recorded.~Target VAS score for NSAID is >4; if there is no response to NSAID and pain is worsening opioid drugs will be applied (this is our routine clinical practice) NSAID: Diclofenac sodium 75mg per vial; opioid: Tramadol 100mg per vial." (NCT03428152)
Timeframe: postoperative 48 hour follow-up (PACU and ward)
| Intervention | vials (Mean) | |||
|---|---|---|---|---|
| NSAID PACU | Opioid PACU | NSAID ward | Opioid ward | |
| Hypo | 0.8 | 0.1 | 2.83 | 0 |
| NoHypo | 0.96 | 0.36 | 5.77 | 0.63 |
Postoperative Pain Scores
Patients' pain scores will be scored with a 10 cm Visual Analogue Scale (VAS). Each will be scored between 0-10 (0: no pain; 10: worst pain ever) (PACU: Post-anesthesia care unit) VAS-PACU: VAS scores at PACU VAS 1: VAS scores at postoperative 1st hour (ward) VAS 6: VAS scores at postoperative 6th hour (ward) VAS 12: VAS scores at postoperative 12th hour (ward) VAS 24: VAS scores at postoperative 24th hour (ward) VAS 48: VAS scores at postoperative 48th hour (ward) (NCT03428152)
Timeframe: postoperative 48 hour follow-up (PACU and ward)
| Intervention | units on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| VAS PACU | VAS 1 | VAS 6 | VAS 12 | VAS 24 | VAS 48 | |
| Hypo | 4.76 | 3.7 | 1.9 | 0.83 | 0.53 | 0.2 |
| NoHypo | 7.38 | 6.66 | 4.23 | 3.16 | 2.1 | 1.2 |
Reviews
12 reviews available for phenol and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; | 2000 |
Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling.
Topics: Carcinogenesis; Coumaric Acids; Humans; Neoplasms; Phenol; Signal Transduction | 2022 |
Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols.
Topics: Aging; Animals; Cell Proliferation; Cell Survival; Humans; Mammals; Neoplasms; Phenol; Phenols; Telo | 2023 |
Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agent | 2021 |
The role of chemical neurolysis in cancer pain.
Topics: Animals; Ethanol; Glycerol; Humans; Neoplasms; Nerve Block; Pain; Pain Management; Phenol | 2010 |
Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives.
Topics: Animals; Biomarkers, Tumor; Epithelial-Mesenchymal Transition; Humans; Hydroxybenzoates; Neoplasm In | 2012 |
[Neurolytic blocks for cancer pain--still a useful therapeutic strategy].
Topics: Central Nervous System Depressants; Ethanol; Humans; Neoplasms; Nerve Block; Pain, Intractable; Phen | 2004 |
Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carcinogens; Epigenesis, Genetic; Free Radical Scav | 2006 |
Perylenequinones in photodynamic therapy: cellular versus vascular response.
Topics: Animals; Anthracenes; Apoptosis; Blood Vessels; Humans; Neoplasms; Perylene; Phenol; Photochemothera | 2006 |
[Cancer pain treatment with nerve blocks and neuroablative procedures].
Topics: Humans; Neoplasms; Nerve Block; Pain Management; Palliative Care; Phenol; Subarachnoid Space | 2007 |
Phenol.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Humans; Mutagenicity Tests; Mutagens; Neoplasms; Neopla | 1999 |
[Chemical neurolysis in advanced neoplasms].
Topics: Anesthesia, Epidural; Humans; Neoplasms; Nerve Block; Pain, Intractable; Palliative Care; Phenol; Ph | 1985 |
Trials
2 trials available for phenol and Neoplasms
| Article | Year |
|---|---|
Fluoroscopic anterior approach versus ultrasound guided superior hypogastric plexus neurolysis in cancer pelvic pain: a randomized controlled study.
Topics: Bupivacaine; Cancer Pain; Fluoroscopy; Humans; Hypogastric Plexus; Neoplasms; Nerve Block; Pelvic Pa | 2022 |
Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome.
Topics: Aged; Aged, 80 and over; Cordotomy; Female; Humans; Injections; Male; Middle Aged; Neoplasm Invasive | 1994 |
Other Studies
53 other studies available for phenol and Neoplasms
| Article | Year |
|---|---|
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Enzyme Activation; Ethylenediamines | 2013 |
Ultrasound responsive self-assembled micelles loaded with hypocrellin for cancer sonodynamic therapy.
Topics: Cell Line, Tumor; Humans; Micelles; Nanoparticles; Neoplasms; Perylene; Phenol; Quinones; Reactive O | 2021 |
Iridium(III)-Cp*-(imidazo[4,5-
Topics: Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Coordination C | 2022 |
Scalable Synthesis and Cancer Cell Cytotoxicity of Rooperol and Analogues.
Topics: Catechols; Neoplasms; Phenol; Phenols; Polyphenols | 2022 |
Descriptive analysis of dietary (poly)phenol intake in the subcohort MAX from DCH-NG: "Diet, Cancer and Health-Next Generations cohort".
Topics: Diet; Female; Humans; Male; Neoplasms; Phenol; Phenols; Polyphenols | 2023 |
l-Amino Acid Based Phenol- and Catechol-Functionalized Poly(ester-urethane)s for Aromatic π-Interaction Driven Drug Stabilization and Their Enzyme-Responsive Delivery in Cancer Cells.
Topics: Amino Acids; Antineoplastic Agents; Catechols; Doxorubicin; Drug Carriers; Esters; Levodopa; Neoplas | 2022 |
Response to: 'Phenol spread in erector spinae plane block for cancer pain' by Hernández-Porras
Topics: Cancer Pain; Humans; Neoplasms; Nerve Block; Pain, Postoperative; Paraspinal Muscles; Phenol | 2023 |
Natural-Origin Hypocrellin-HSA Assembly for Highly Efficient NIR Light-Responsive Phototheranostics against Hypoxic Tumors.
Topics: Animals; Cell Line, Tumor; Female; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Mice, Nude; N | 2019 |
Phenol spread in erector spinae plane block for cancer pain.
Topics: Cancer Pain; Humans; Neoplasms; Nerve Block; Phenol; Phenols | 2020 |
A safer step-by-step approach for erector spinae plane phenol neurolytic blocks.
Topics: Cancer Pain; Humans; Neoplasms; Nerve Block; Paraspinal Muscles; Phenol | 2021 |
In reply: A safer step-by-step approach for erector spinae plane phenol neurolytic blocks.
Topics: Cancer Pain; Humans; Neoplasms; Nerve Block; Paraspinal Muscles; Phenol | 2021 |
Phenol-Boronic surface functionalization of gold nanoparticles; to induce ROS damage while inhibiting the survival mechanisms of cancer cells.
Topics: Antineoplastic Agents; Boron; Cell Line, Tumor; Drug Delivery Systems; Gold; Metal Nanoparticles; Na | 2021 |
Immolation of p-Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody-Drug Conjugates with Phenol-Containing Payloads.
Topics: Antineoplastic Agents, Immunological; Brentuximab Vedotin; Cell Line, Tumor; Cell Survival; Cyclopro | 2018 |
Fractionation of the more active extracts of Geranium molle L.: a relationship between their phenolic profile and biological activity.
Topics: Acetone; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Cell Survival; | 2018 |
Internal heavy atom effect of Au(III) and Pt(IV) on hypocrellin A for enhanced in vitro photodynamic therapy of cancer.
Topics: Cell Survival; Coordination Complexes; Gold; HeLa Cells; Humans; Metals, Heavy; Microscopy, Fluoresc | 2013 |
A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Fluorides; Gadolinium; HeLa Cells; Humans; Infrared | 2013 |
Dual-modal imaging and photodynamic therapy using upconversion nanoparticles for tumor cells.
Topics: Contrast Media; Fluorides; Gadolinium; HEK293 Cells; HeLa Cells; Humans; Magnetic Resonance Imaging; | 2014 |
Multicolor imaging and the anticancer effect of a bifunctional silica nanosystem based on the complex of graphene quantum dots and hypocrellin A.
Topics: Antineoplastic Agents; Graphite; HeLa Cells; Humans; Nanoparticles; Neoplasms; Optical Imaging; Pery | 2015 |
Shotgun proteomics on tissue specimens extracted with Acid guanidinium-thiocyanate-phenol-chloroform.
Topics: Animals; Chloroform; Guanidines; Humans; Neoplasms; Phenol; Proteins; Proteome; Proteomics; Thiocyan | 2015 |
808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.
Topics: Animals; Apoptosis; Drug Delivery Systems; Female; Fluorides; HeLa Cells; Humans; Hyaluronic Acid; M | 2016 |
Phenolic compounds and their anti-oxidative properties and protein kinase inhibition from the Chinese mangrove plant Laguncularia racemosa.
Topics: Animals; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Combretaceae; Humans; Models, Molecular | 2010 |
Discovery of isoerianin analogues as promising anticancer agents.
Topics: Antineoplastic Agents; Bibenzyls; Binding Sites; Cell Division; Cell Line, Tumor; Computer Simulatio | 2011 |
External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Topics: Antineoplastic Agents; Cell Death; Cell Survival; Drug Delivery Systems; Gold; HeLa Cells; Humans; N | 2012 |
Use of injectable spasticity management agents in a cancer center.
Topics: Botulinum Toxins, Type A; Cancer Care Facilities; Female; Humans; Injections; Male; Middle Aged; Mus | 2013 |
Efficacy of hypocrellin pharmacokinetics in phototherapy.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; Bambusa; bcl-2-Associated X Protein; Blotting, We | 2002 |
Differentiation of sera on phenol; a preliminary report.
Topics: Blood Proteins; Cell Differentiation; Humans; Neoplasms; Oxidation-Reduction; Phenol; Phenols | 1954 |
The tumor-promoting action of phenol and related compounds for mouse skin.
Topics: Animals; Carcinogens; Mice; Neoplasms; Phenol; Phenols | 1959 |
A tumor-producing factor extracted by phenol from papillomatous tissue (Shope) of cottontail rabbits.
Topics: Animals; Humans; Neoplasms; Neoplasms, Experimental; Papilloma; Phenol; Phenols; Rabbits | 1960 |
[Chemical study of the "ribonucleic acid fraction" from healthy and cancerous tissue prepared by various methods of phenol extraction].
Topics: Health; Neoplasms; Phenol; Phenols; RNA | 1961 |
Fractionation of ribonucleic acids with phenol. II. The relationship between RNA fractions in rat ascites hepatoma.
Topics: Ascites; Carcinoma, Hepatocellular; Chemical Fractionation; Liver Neoplasms; Neoplasms; Phenol; Phen | 1960 |
[New experimental clinical aspects in the chemotherapy of cancer by means of a phenol derivative].
Topics: Antineoplastic Agents; Neoplasms; Phenol; Phenols | 1960 |
Intrathecal phenol block in treatment of intractable pain of malignant disease.
Topics: Anesthesia, Spinal; Humans; Hypothermia, Induced; Neoplasms; Pain; Pain, Intractable; Phenol; Phenol | 1963 |
Separation of phenol and deoxyribonucleic acid by Sephadex gel filtration.
Topics: Chromatography, Gel; Dextrans; DNA; DNA, Neoplasm; Ion Exchange Resins; Neoplasms; Phenol; Phenols | 1962 |
PAIN RELIEF IN CANCEROUS PATIENTS BY THE USE OF PHENOL SOLUTION.
Topics: Humans; Injections; Injections, Spinal; Neoplasms; Pain; Pain Management; Phenol; Phenols; Subarachn | 1963 |
[INTRATHECAL PHENOL FOR INTRACTABLE CANCER PAIN].
Topics: Humans; Injections; Injections, Spinal; Neoplasms; Pain; Pain, Intractable; Palliative Care; Pharmac | 1964 |
COMMENTS ON THE USE OF INTRASPINAL PHENOL-PANTOPAQUE FOR RELIEF OF PAIN AND SPASTICITY.
Topics: Contrast Media; Drug Therapy; Humans; Injections; Iophendylate; Leg; Muscle Spasticity; Neck; Neopla | 1963 |
HISTOLOGICAL FINDINGS FOLLOWING INTRATHECAL INJECTIONS OF PHENOL SOLUTIONS FOR RELIEF OF PAIN.
Topics: Cats; Drug Therapy; Glycerol; Histology; Humans; Injections; Injections, Spinal; Meningitis; Neoplas | 1964 |
FURTHER EXPERIENCES WITH INTRATHECAL PHENOL FOR THE RELIEF OF PAIN.
Topics: Humans; Injections; Injections, Spinal; Neoplasms; Pain; Palliative Care; Phenol; Phenols; Terminal | 1964 |
Further experiences with intrathecal and subdural phenol observations on two forms of pain.
Topics: Humans; Neoplasms; Pain; Phenol; Phenols | 1960 |
Intrathecal use of phenol for the relief of chronic severe pain.
Topics: Anesthesia; Anesthesia, Conduction; Chronic Pain; Humans; Neoplasms; Neuralgia; Pain Management; Phe | 1962 |
Intrathecal neurolytic blocks for the relief of cancer pain.
Topics: Aged; Anesthetics, Local; Clinical Trials as Topic; Ethanol; Female; Humans; Injections, Spinal; Mal | 2003 |
[Poisonous monitor. The toxic chemical phenol].
Topics: Air Pollution, Indoor; Child; Computer Terminals; Equipment Safety; Humans; Mutation; Neoplasms; Occ | 2004 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
A new technique for superior hypogastric plexus block: the posteromedian transdiscal approach.
Topics: Aged; Autonomic Nerve Block; Contrast Media; Female; Fluoroscopy; Humans; Hypogastric Plexus; Lumbos | 2005 |
Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line.
Topics: Annexin A5; Annexins; Apoptosis; Cell Death; Cell Line, Tumor; Cell Separation; Coculture Techniques | 2005 |
Combination of porphyrins and DNA-alkylation agents: synthesis and tumor cell apoptosis induction.
Topics: Alkylation; Apoptosis; Cations; Cell Line, Tumor; DNA; DNA Fragmentation; Humans; Inhibitory Concent | 2006 |
Photosensitizer effects on cancerous cells: a combined study using synchrotron infrared and fluorescence microscopies.
Topics: Cell Nucleus; Cytoplasm; HeLa Cells; Humans; Infrared Rays; Intracellular Space; Light; Microscopy; | 2008 |
Spinal neurolysis for cancer pain: indications and recent results.
Topics: Clinical Protocols; Ethanol; Female; Humans; Injections, Spinal; Male; Middle Aged; Neoplasms; Nerve | 1994 |
Neurolytic thoracic paravertebral block in cancer pain. A clinical report.
Topics: Acute Disease; Adult; Aged; Analgesics; Anesthetics, Local; Bupivacaine; Chronic Disease; Female; Fo | 1998 |
Mapping the spread of epidural phenol in cancer pain patients by radionuclide admixture and epidural scintigraphy.
Topics: Adult; Aged; Epidural Space; Humans; Injections, Epidural; Middle Aged; Neoplasms; Nerve Block; Pain | 1992 |
Mortality among industrial workers exposed to phenol.
Topics: Adult; Aged; Cohort Studies; Coronary Artery Disease; Demography; Emphysema; Formaldehyde; Humans; L | 1991 |
[The control of pain].
Topics: Adult; Aged; Chlorpromazine; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Nerve Block; Pa | 1986 |
Effect of immunotherapy with a saline phenol extract of allogeneic tumour on E-rosette counts in horn cancer-affected cattle.
Topics: Analysis of Variance; Animals; Carcinoma, Squamous Cell; Cattle; Cattle Diseases; Female; Horns; Imm | 1986 |
[Analgesic therapy of cancer outpatients].
Topics: Adult; Aged; Ambulatory Care; Analgesics; Drug Evaluation; Ethanol; Glycerol; Humans; Middle Aged; N | 1987 |